Sara Saliba MD, RD, LDN
@SaraSalibaMDRD
Endocrinology Fellow at Johns Hopkins | Licensed Dietitian | Aspiring Endocrinologist & Obesity Medicine Specialist
You know the place where you work is beautiful when a casual picture snapped with your phone looks like an actual postcard. No filter needed. Feeling #blessed and #grateful ☀️📷 #stunning #nature #medicine #doctor #clevelandclinic #cleveland #sun #beautiful #resident #MedTwitter
Proud of my friend and co-fellow for receiving an Outstanding Abstract Award 🙌🏼
Congrats to our second year fellow Dr Vidisha Master on presenting her poster at #ENDO2025 and receiving Outstanding Abstract Award! 👏🏼
Highlight of every ENDO is always our Hopkins alumni dinner, where we reconnect, share laughs, and proudly celebrate the bond we all share at @EndoHopkins! #ENDO2025 #Endofamily
Had a “gland” old time welcoming the new first year endocrine fellows to Baltimore! @EndoHopkins @HopkinsMedicine #endocrinology #endocrine #fellowship
Among many highlights today #ADA2025 New Bimagrumab data #weightloss #obesity
Absolutely thrilled that my application for the Endocrine Society’s annual Obesity Fellows program was accepted! Looking forward to expanding my knowledge about this complex condition. DC, here I come! @TheEndoSociety @ObesitySociety @EndoHopkins @drbutsch #obesity #endocrinology
Mild autonomous #cortisol secretion (#MACS) associated with #unilateral #adrenal #incidentalomas is responsible for secondary #hypertension that can be safely improved by minimally-invasive #adrenalectomy thelancet.com/journals/landi… #adrenal
Novo Nordisk's Ozempic wins FDA approval for chronic kidney disease cnbc.com/2025/01/28/nov…
Subcutaneous Amycretin moves the needle with up to 22% weight loss over 36 wks in P2 #obesity @novonordisk novonordisk.com/news-and-media…
This has been needed for a long time! Redefining obesity A new report of @TheLancetEndo commission that overrides current BMI categories and better defines features and pathophysiologic consequences of pre-clinical and clinical obesity thelancet.com/journals/landi… open-access (such as…
New—The Lancet Diabetes & Endocrinology Commission on: Definition and diagnostic criteria of #clinical #obesity thelancet.com/journals/landi… #FREE to read with registration (also FREE)
A highlight of every holiday season for our first year fellows (and some lucky junior faculty 😁!) is the invitation to dinner at our esteemed faculty Dr. David Cooper's home! Always such a merry and lovely time! @SaraSalibaMDRD @SudiSarkar
Congratulations to this year's Tabb Moore Teaching Award to our faculty @schencardenas, who is an @EndoHopkins graduate himself! Thank you for making such an impactful contribution to our fellows' education!
Rainy Friday at Hopkins ☂️ @JohnsHopkinsDOM @EndoHopkins #baltimore
New P1 4 week data #OW2024 for the once daily orally administered peptide GIPR-GLP-1R co-agonist VK-2735 #obesity @Viking_VKTX #weightloss
#Tirzepatide SURMOUNT-1 three year efficacy outcomes just presented at #ObesityWeek2024 👀 📉Sustained weight loss of 22.9% or an average 54lbs over 3 years 🔽94% reduction in risk of progression to diabetes. Number Needed to Treat = 9 🤯 🫀Improvement in metabolic parameters…
Semaglutide 2.4mg weekly for 24 weeks resulted in a reduction in albuminuria in patients with overweight/ #obesity and non-diabetic nephropathy @NatureMedicine nature.com/articles/s4159…
⚡️Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial⚡️ 👉9,650 people with T2D, CVD and/or CKD 👉49% got SGLT2i at some point during trial novonordisk.com/content/nncorp…
#Obesity and cardiovascular disease: an important @escardio clinical consensus statement Obesity recognised as a disease #CVD #NCDs academic.oup.com/eurheartj/adva…
Check out the CGM gun show 😁 on our new fellows during orientation week! Special thank you to our #Diabetes Center RN Adena Goldstein for the session!